Overview
- Editors:
-
-
David Young
-
University of Maryland at Baltimore, Baltimore, USA
-
John G. Devane
-
Elan Corporation, plc, Athlone, Ireland
-
Jackie Butler
-
Elan Corporation, plc, Athlone, Ireland
Access this book
Other ways to access
Table of contents (26 chapters)
-
-
-
- Brian R. Rohrs, John W. Skoug, Gordon W. Halstead
Pages 17-30
-
- Pradeep Sathe, Yi Tsong, Vinod P. Shah
Pages 31-42
-
-
-
- Adrian Dunne, Tom O’Hara, John Devane
Pages 67-86
-
- David Young, James A. Dowell, Deborah A. Piscitelli, John Devane
Pages 87-91
-
-
-
- C. D. Melia, P. Marshall, P. Stark, S. Cunningham, A. Kinahan, J. Devane
Pages 129-135
-
- P. Stark, A. Kinahan, S. Cunningham, J. Butler, T. O’Hara, A. Dunne et al.
Pages 137-147
-
-
- Deborah A. Piscitelli, David Young
Pages 159-166
-
- Tom O’Hara, Adrian Dunne, Audrey Kinahan, Sean Cunningham, Paul Stark, John Devane
Pages 167-171
-
- Guoliang Cao, Charles Locke
Pages 173-180
-
- A. Raoof, D. Moriarty, D. Brayden, O. I. Corrigan, I. Cumming, J. Butler et al.
Pages 181-189
-
-
- Jeanne Mendell-Harary, James Dowell, Sian Bigora, Deborah Piscitelli, Jackie Butler, Colm Farrell et al.
Pages 199-206
-
- Sian Bigora, Deborah Piscitelli, James Dowell, Jackie Butler, Colm Farrell, John Devane et al.
Pages 207-215
About this book
This book represents the invited presentations and some of the posters presented at the conference entitled "In Vitro-In Vivo Relationship (IVIVR) Workshop" held in Sep tember, 1996. The workshop was organized by the IVIVR Cooperative Working Group which has drawn together scientists from a number of organizations and institutions, both academic and industrial. In addition to Elan Corporation, which is a drug delivery com pany specializing in the development of ER (Extended Release) dosage forms, the IVIVR Cooperative Working Group consists of collaborators from the University of Maryland at Baltimore, University College Dublin, Trinity College Dublin, and the University of Not tingham in the UK. The principal collaborators are: Dr. Jackie Butler, Elan Corporation Prof. Owen Corrigan, Trinity College Dublin Dr. lain Cumming, Elan Corporation Dr. John Devane, Elan Corporation Dr. Adrian Dunne, University College Dublin Dr. Stuart Madden, Elan Corporation Dr. Colin Melia, University of Nottingham Mr. Tom O'Hara, Elan Corporation Dr. Deborah Piscitelli, University of Maryland at Baltimore Dr. Araz Raoof, Elan Corporation Mr. Paul Stark, Elan Corporation Dr. David Young, University of Maryland at Baltimore The purpose of the workshop was to discuss new concepts and methods in the devel opment of in vitro-in vivo relationships for ER products. The original idea went back ap proximately 15 months prior to the workshop itself. For some time, the principal collaborators had been working together on various aspects of dosage form development.